Starr, Stuart E <br/><br/>
Efavirenz liquid formulation in human immunodeficiency virus-infected children.  [electronic resource] 

 -  The Pediatric infectious disease journal  Jul 2002 
 - 659-63 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0891-3668 
<br/><br/><label>Standard No.: </label>10.1097/00006454-200207000-00011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Alkynes<br/>Benzoxazines<br/>Child<br/>Child, Preschool<br/>Cyclopropanes<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>HIV Infections--diagnosis<br/>HIV Protease Inhibitors--administration & dosage<br/>HIV-1--isolation & purification<br/>Humans<br/>Male<br/>Nelfinavir--administration & dosage<br/>Oxazines--administration & dosage<br/>RNA, Viral--analysis<br/>Sensitivity and Specificity<br/>Severity of Illness Index<br/>Single-Blind Method<br/>Survival Analysis<br/>Treatment Outcome<br/>Viral Load